📋 Hexagon Nutrition Ltd IPO 2026 — Date, Price Band, GMP & Allotment
Hexagon Nutrition Ltd IPO is a mainboard book-built issue opening on 5 June 2026 and closing on 9 June 2026. The company is raising ₹138.87 Crore entirely through an Offer for Sale (OFS) of 3,08,59,704 equity shares at a price band of ₹42–₹45 per share. The Hexagon Nutrition IPO allotment is scheduled for 10 June 2026 and shares are expected to list on both NSE and BSE on 12 June 2026. Check all 2026 IPOs on IPOView.
🏢 About Hexagon Nutrition Ltd — Company Overview
Founded in 1993 and headquartered in Mumbai, Hexagon Nutrition Ltd is a three-decade-old nutrition science company engaged in developing and manufacturing micronutrient premixes, clinical nutrition supplements, therapeutic foods, and ready-to-use nutritional formulations. The company serves FMCG food and beverage manufacturers, healthcare consumers, international nutrition programs, and government-funded public health initiatives globally.
Its product portfolio spans fortification premixes for staple foods, clinical nutrition for disease management, ready-to-use therapeutic foods (RUTF) for severe acute malnutrition treatment, and wellness nutrition products. Hexagon Nutrition has a strong international presence — supplying to global nutrition programs and FMCG companies across multiple geographies. Promoters currently hold 89.41% pre-IPO, which will reduce to 64.29% post-listing. Financially, revenue grew from ₹304.62 Crore in FY24 to ₹331.29 Crore in FY25 while PAT doubled from ₹12.21 Crore to ₹24.38 Crore — an outstanding 99.7% profit growth.
📊 Hexagon Nutrition IPO Details at a Glance
🔹 Exchange: NSE and BSE (Mainboard)
🔹 Issue Type: Book Built Mainboard IPO (100% OFS)
🔹 Price Band: ₹42 – ₹45 per share
🔹 Face Value: ₹1 per share
🔹 Lot Size: 333 shares
🔹 Minimum Retail Investment: ₹14,985 (1 lot = 333 shares at ₹45)
🔹 Issue Size: ₹138.87 Crore (3,08,59,704 shares OFS)
🔹 QIB Quota: 50% | NII: 15% | Retail: 35%
🔹 Lead Managers: Cumulative Capital Pvt. Ltd., Catalyst Capital Partners Pvt. Ltd.
🔹 Registrar: Kfin Technologies Ltd.
🔹 Anchor Date: 4 June 2026
🔹 FY25 Revenue: ₹331.29 Crore | FY25 PAT: ₹24.38 Crore (+99.7%)
🔹 Market Cap: ~₹553 Crore
🔹 GMP Today: ₹0 — Check live on IPOView
📅 Hexagon Nutrition IPO Timeline — Important Dates
🗓️ Anchor Investor Date: 4 June 2026 (Thursday)
🗓️ IPO Open Date: 5 June 2026 (Friday)
🗓️ IPO Close Date: 9 June 2026 (Tuesday)
🗓️ Allotment Date: 10 June 2026 (Wednesday)
🗓️ Demat Credit: 11 June 2026 (Thursday)
🗓️ Listing Date: 12 June 2026 (Friday) — NSE & BSE
📈 Hexagon Nutrition IPO GMP Today
The Hexagon Nutrition IPO GMP today stands at ₹0 — no grey market premium has been established ahead of the 5 June 2026 subscription opening. Track live Hexagon Nutrition GMP updates on IPOView. Also check all 2026 IPO GMP on IPOView.
✅ Hexagon Nutrition IPO — Strengths
✔️ 30+ Year Nutrition Science Heritage Since 1993: Hexagon Nutrition has been developing nutrition solutions for over three decades — giving it deep formulation expertise, regulatory compliance capabilities, and established relationships with FMCG manufacturers and international nutrition organizations.
✔️ Nearly 100% PAT Growth in FY25: Profit after tax grew from ₹12.21 Crore to ₹24.38 Crore in FY25 — a 99.7% surge — demonstrating exceptional margin expansion alongside steady revenue growth of 8.8% for Hexagon Nutrition.
✔️ Global Nutrition Program Exposure: Hexagon Nutrition's products are used in international nutrition programs — including ready-to-use therapeutic foods for malnutrition treatment — giving it a meaningful international revenue stream that is largely independent of domestic market cycles.
✔️ India's Growing Micronutrient Fortification Market: Government-mandated food fortification programs and rising consumer health awareness are creating strong and growing demand for Hexagon Nutrition's micronutrient premix products from both government and private sector FMCG clients.
✔️ Mainboard Listing — Better Liquidity: Unlike SME IPOs, a mainboard NSE and BSE listing provides Hexagon Nutrition shareholders with significantly better post-listing trading liquidity and analyst coverage.
⚠️ Hexagon Nutrition IPO — Risks
❌ 100% OFS — No Fresh Capital for Company: The entire ₹138.87 Crore raised goes to selling shareholders — Hexagon Nutrition receives zero IPO proceeds for business growth or expansion. This is a pure exit event for existing investors, not a capital-raising exercise for the company.
❌ Promoter Stake Declining from 89.41% to 64.29%: A 25% reduction in promoter stake through a single IPO OFS raises questions about promoter conviction in the near-term valuation ceiling for Hexagon Nutrition.
❌ Small Issue Size Limits Institutional Interest: At ₹138.87 Crore, the Hexagon Nutrition IPO is on the smaller end of mainboard IPOs — which may limit institutional and large HNI interest compared to larger mainboard offerings that attract more analyst coverage and fund manager attention.
❌ GMP Currently at Zero: The absence of any grey market premium for Hexagon Nutrition ahead of subscription suggests neutral to cautious grey market sentiment at this stage.
🎯 Should You Apply for Hexagon Nutrition IPO?
Hexagon Nutrition IPO is suited for investors who value the company's three-decade nutrition heritage, near-100% PAT growth, and global nutrition program exposure. The mainboard listing on both NSE and BSE provides better post-listing liquidity than SME alternatives. However, the 100% OFS structure — meaning all proceeds go to sellers, not the company — and the flat GMP require investors to focus on long-term fundamentals rather than short-term listing gains. Best suited for a medium to long-term investment horizon of 18–36 months. Check all upcoming IPOs in 2026 on IPOView.
🔍 Conclusion
Track Hexagon Nutrition IPO GMP, subscription status, allotment date and listing price on IPOView. Also check all upcoming 2026 IPOs on IPOView.